Corvus Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Corvus Pharmaceuticals, Inc. (CRVS) is 19.81

According to Corvus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.81. This represents a change of 83.37% compared to the average of 10.81 of the last 4 quarters.

Corvus Pharmaceuticals, Inc. (CRVS) Historical Current Ratio (quarterly & annually)

How has CRVS Current Ratio performed in the past?

The mean historical Current Ratio of Corvus Pharmaceuticals, Inc. over the last ten years is 7.67. The current 19.81 Current Ratio has changed 25.75% with respect to the historical average. Over the past ten years (40 quarters), CRVS's Current Ratio was at its highest in in the June 2016 quarter at 42.55. The Current Ratio was at its lowest in in the September 2024 quarter at 0.92.

Corvus Pharmaceuticals, Inc. (CRVS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Corvus Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corvus Pharmaceuticals, Inc. (CRVS) Average Current Ratio

How has CRVS Current Ratio performed in the past?

The current Current Ratio of Corvus Pharmaceuticals, Inc. (CRVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corvus Pharmaceuticals, Inc. (CRVS) Current Ratio vs. Peers

How is CRVS’s Current Ratio compared to its peers?

Corvus Pharmaceuticals, Inc.’s Current Ratio is greater than Olema Pharmaceuticals, Inc. (10.88), greater than Ventyx Biosciences, Inc. (17.86), greater than Prothena Corporation plc (10.43), greater than REGENXBIO Inc. (2.62), greater than Akebia Therapeutics, Inc. (1.40), greater than Verastem, Inc. (3.04), greater than Gossamer Bio, Inc. (2.20), greater than KalVista Pharmaceuticals, Inc. (5.58), greater than Absci Corporation (6.59), greater than Compass Therapeutics, Inc. (19.04),

Build a custom stock screener for Corvus Pharmaceuticals, Inc. (CRVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corvus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corvus Pharmaceuticals, Inc. (CRVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corvus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.